Hydrochloric Acid in Gastric Juice: Concentration, Physiological Role, and Clinical Relevance

Gastric juice is a complex secretory product of the parietal (oxyntic) cells, with hydrochloric acid (HCl) as its defining component. The luminal HCl concentration of 0.5–1% (∼150–160 mM, pH 1–2) creates one of the most acidic environments in the human body—essential for digestion and defense.

Composition of Gastric Juice

Component	Source	Function
HCl (0.5–1%)	Parietal cells (H⁺/K⁺-ATPase)	Acidic pH, pepsin activation, pathogen kill
Pepsinogen	Chief cells	Inactive precursor → pepsin at low pH
Intrinsic factor	Parietal cells	B₁₂ absorption in terminal ileum
Mucus (MUC5AC, MUC6)	Surface mucous & neck cells	Barrier, lubrication, HCO₃⁻ transport
Bicarbonate (HCO₃⁻)	Surface epithelial cells	Mucosal surface pH gradient (pH 7 at epithelium)
Water, electrolytes	Parietal/other cells	Volume, ion transport

Physiological Roles of HCl

1. Pepsin activation: Converts pepsinogen → pepsin (optimal pH 1.5–2.5); pepsin hydrolyzes peptide bonds
2. Protein denaturation: Unfolds tertiary structure, exposing cleavage sites
3. Pathogen barrier: Kills most ingested bacteria, viruses, fungi (pH <3.0 is bactericidal for many)
4. Iron and calcium solubilization: Converts Fe³⁺ → Fe²⁺ (absorbable); keeps Ca²⁺ in solution
5. Hormonal regulation: Low pH stimulates secretin (→ pancreatic HCO₃⁻) and CCK (→ gallbladder contraction, pancreatic enzymes)

Clinical Relevance

• Hypochlorhydria/achlorhydria: Atrophic gastritis, H. pylori, PPIs, age → B₁₂ malabsorption, iron deficiency, SIBO, enteric infections
• Hyperchlorhydria: Zollinger-Ellison (gastrinoma), H. pylori (early), stress → ulcer risk
• PPI therapy: Suppresses H⁺/K⁺-ATPase → pH 4–6; long-term use associated with microbiome shifts, fracture risk, kidney disease, dementia (associational)

The gastric acid barrier is a masterpiece of evolutionary engineering—potent enough to digest protein, yet contained by a multi-layered mucosal defense that prevents autodigestion.